Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed
Publication date
2024-01
Authors
International BFM Study Group (I-BFM), Innovative Therapies for Children with Cancer (ITCC), and the European Society for Paediatric Oncology (SIOPE)
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Taverne, Journal Article
Citation
International BFM Study Group (I-BFM), Innovative Therapies for Children with Cancer (ITCC), and the European Society for Paediatric Oncology (SIOPE) 2024, 'Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers : Why Alternative Development Paths Are Needed', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 42, no. 3, pp. 253-257. https://doi.org/10.1200/JCO.23.01314